Immortal Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-06-2024
- Paid Up Capital ₹ 0.10 M
as on 03-06-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 54.65%
(FY 2020)
- Profit -163.16%
(FY 2020)
- Ebitda -130.71%
(FY 2020)
- Net Worth -23.49%
(FY 2020)
- Total Assets 8.53%
(FY 2020)
About Immortal Biotech
The Corporate was formerly known as Immortal Biotec Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tarun Arora, Narender Kumar, and Rajesh Utreja serve as directors at the Company.
- CIN/LLPIN
U24100HR2014PTC052081
- Company No.
052081
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Sonipat, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Immortal Biotech Private Limited offer?
Immortal Biotech Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Probiotic And Prebiotic Drugs, Prebiotic & Probiotic Sachet, Mineral Supplement, Iron Syrup, Protein Powder, Common Disease Medicines, Pharmaceutical Tablets, Multivitamin Syrup & Drops.
Who are the key members and board of directors at Immortal Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tarun Arora  | Director | 01-Sep-2016 | Current |
| Narender Kumar | Director | 01-Sep-2016 | Current |
| Rajesh Utreja | Additional Director | 29-Jul-2014 | Current |
Financial Performance of Immortal Biotech.
Immortal Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 54.65% increase. The company also saw a substantial fall in profitability, with a 163.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Immortal Biotech?
Unlock access to Immortal Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Immortal Biotech?
Unlock and access historical data on people associated with Immortal Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Immortal Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Immortal Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
